Stille AB (STO:STIL)
| Market Cap | 2.15B +5.8% |
| Revenue (ttm) | 679.58M +25.1% |
| Net Income | 72.59M +33.0% |
| EPS | 8.08 +33.0% |
| Shares Out | 8.99M |
| PE Ratio | 29.58 |
| Forward PE | 22.87 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,537 |
| Open | 240.00 |
| Previous Close | 240.00 |
| Day's Range | 231.50 - 240.00 |
| 52-Week Range | 143.00 - 283.00 |
| Beta | 0.37 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 23, 2026 |
About Stille AB
Stille AB develops, manufactures, and distributes medtech products in Sweden, Germany, the United Kingdom, Switzerland, North America, the United States, and internationally. It operates through the Surgical Instruments and Surgical Tables segments. The Surgical Instruments segment offers surgical scissors, including SuperCut, eye, blepharoplasty, operating, vascular, tenotomy, and face-lift scissors; colon, gall duct, multi-purpose, tangential occlusion, peripheral vascular, and anastomosis clamps; skin and nerve hooks, retractors, rib spreade... [Read more]
Financial Performance
In 2025, Stille AB's revenue was 567.63 million, a decrease of -0.41% compared to the previous year's 569.95 million. Earnings were 55.70 million, a decrease of -4.31%.
Financial StatementsNews
Stille AB Earnings Call Transcript: Q2 2026
Q2 delivered record sales with 50% revenue growth and improved profitability, driven by strong demand, operational scaling, and strategic execution. Gross margin declined due to acquisition mix, but EBIT and cash flow rose sharply. Backorder levels remain elevated but are expected to normalize.
Stille AB Quarterly report: Q2 2026
Stille AB has published its Q2 2026 quarterly earnings report on July 23, 2026.
Stille AB Slides: Q2 2026
Stille AB has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 23, 2026.
Stille AB (OSTO:STIL) Q2 2026: Everything You Need To Know Ahead Of Earnings
Stille AB (OSTO:STIL) Q2 2026: Everything You Need To Know Ahead Of Earnings
Stille AB Earnings Call Transcript: Q1 2026
Revenue grew 39% year-over-year to SEK 179 million, with strong organic growth and improved EBIT margin. Both business segments performed well, supported by operational improvements and the successful integration of Surgical Holdings. Backorder normalization and M&A remain key priorities.
Stille AB Quarterly report: Q1 2026
Stille AB has published its Q1 2026 quarterly earnings report on April 24, 2026.
Stille AB Quarterly report: Q4 2025
Stille AB has published its Q4 2025 quarterly earnings report on February 12, 2026.
Stille AB Annual report: Q4 2025
Stille AB has published its Q4 2025 annual report on February 12, 2026.
Stille AB (OSTO:STIL) Q4 2025: Everything You Need to Know Ahead of Earnings
Stille AB (OSTO:STIL) Q4 2025: Everything You Need to Know Ahead of Earnings
Stille AB Quarterly report: Q3 2025
Stille AB has published its Q3 2025 quarterly earnings report on October 23, 2025.
Stille AB (OSTO:STIL) Q3 2025 Earnings Report Preview: What To Expect
Stille AB (OSTO:STIL) Q3 2025 Earnings Report Preview: What To Expect
Stille AB Slides: Investor presentation
Stille AB has posted slides in relation to its latest quarterly earnings report, which was published on September 12, 2025.
Stille AB (OSTO:STIL) Q4 2024 Earnings Report Preview: What to Look For
Stille AB (OSTO:STIL) Q4 2024 Earnings Report Preview: What to Look For